When I say VAERS notoriously undercounts, I’m referring to the literature on the subject. For example, the Harvard report Electronic Support for Public Health - Vaccine Adverse Event Reporting System (ESP:VAERS)
https://digital.ahrq.gov/ahrq-funded-projects/electronic-sup...:
Adverse events from drugs and vaccines are common, but underreported.
Although 25% of ambulatory patients experience an adverse drug event,
less than 0.3% of all adverse drug events and 1-13% of serious events
are reported to the Food and Drug Administration (FDA).
Likewise, fewer than 1% of vaccine adverse events are reported. Low
reporting rates preclude or slow the identification of “problem” drugs
and vaccines that endanger public health. New surveillance methods for
drug and vaccine adverse effects are needed. Barriers to reporting
include a lack of clinician awareness, uncertainty about when and what
to report, as well as the burdens of reporting: reporting is not part
of clinicians’ usual workflow, takes time, and is duplicative.
See also ‘The reporting sensitivities of two passive surveillance systems for vaccine adverse events’
https://ajph.aphapublications.org/doi/abs/10.2105/AJPH.85.12.... Regarding VAERS:
Sensitivities ranged from 72% for poliomyelitis after
the oral poliovirus vaccine to less than 1% for rash
and thrombocytopenia after the MMR vaccine.
Regarding your speculation that deaths associated with the Covid-19 vaccines are probably reported at rates higher than that of other vaccines: I have a hard time believing that the report rate is higher than
poliomyelitis after the oral poliovirus vaccine which is itself underreported.
And regarding the protestation that correlation does not imply causation, it’s not on me to prove that the treatment is harmful, and otherwise it’s safe and thus administered—-it’s on you to prove that it confers an all cause mortality benefit. I am aware of no evidence to suggest that such a benefit obtains in children, and suggest that this dearth of evidence explains the failure to approve the vaccines for children in many European countries.